1. Mittal M, Siddiqui MR, Tran K, Reddy SP, Malik AB: Reactive oxygen species in inflammation and tissue injury. Antioxid Redox Signal 2014, 20:1126-1167.
2. Gunawan C, Faiz MB, Mann R, Ting SRS, Sotiriou GA, Marquis CP, Amal R: Nanosilver targets the bacterial cell envelope: the link with generation of reactive oxygen radicals. ACS Appl Mater Interfaces 2020, 12:5557-5568.
3. Kwon N, Kim D, Swamy KMK, Yoon J: Metal-coordinated fluorescent and luminescent probes for reactive oxygen species (ROS) and reactive nitrogen species (RNS). Coord Chem Rev 2021, 427:213581.
4. Closa D: Free radicals and acute pancreatitis: much ado about ... something. Free Radic Res 2013, 47:934-940.
5. Zhao CY, Li Z, Chen JX, Su LC, Wang JQ, Chen DS, Ye JM, Liao NS, Yang HH, Song JB, Shi JJ: Site-specific biomimicry of antioxidative melanin formation and its application for acute liver injury therapy and imaging. Adv Mater 2021, 33:2102391.
6. Zhang DY, Younis MR, Liu HK, Lei S, Wan YL, Qu JL, Lin J, Huang P: Multi-enzyme mimetic ultrasmall iridium nanozymes as reactive oxygen/ nitrogen species scavengers for acute kidney injury management. Biomaterials 2021, 271:120706.
7. Piechota-Polanczyk A, Fichna J: Review article: the role of oxidative stress in pathogenesis and treatment of inflammatory bowel diseases. Naunyn-Schmiedebergs Arch Pharmacol 2014, 387:605-620.
8. Jena G, Trivedi PP, Sandala B: Oxidative stress in ulcerative colitis: an old concept but a new concern. Free Radic Res 2012, 46:1339-1345.
9. Kawanishi S, Hiraku Y, Pinlaor S, Ma N: Oxidative and nitrative DNA damage in animals and patients with inflammatory diseases in relation to inflammation-related carcinogenesis. Biol Chem 2006, 387:365-372.
10. Vaghari-Tabari M, Moein S, Qujeq D, Kashifard M, Hajian-Tilaki K: Positive correlation of fecal calprotectin with serum antioxidant enzymes in patients with inflammatory bowel disease: accidental numerical correlation or a new finding? Am J Med Sci 2018, 355:449-455.
11. Zhu H, Li YR: Oxidative stress and redox signaling mechanisms of inflammatory bowel disease: updated experimental and clinical evidence. Exp Biol Med 2012, 237:474-480.
12. Zhao JL, Gao W, Cai XJ, Xu JJ, Zou DW, Li ZS, Hu B, Zheng YY: Nanozyme-mediated catalytic nanotherapy for inflammatory bowel disease. Theranostics 2019, 9:2843-2855.
13. Weng QJ, Sun H, Fang CY, Xia F, Liao HW, Lee JY, Wang JC, Xie A, Ren JF, Guo X, et al: Catalytic activity tunable ceria nanoparticles prevent chemotherapy-induced acute kidney injury without interference with chemotherapeutics. Nat Commun 2021, 12:1436.
14. Zhang DY, Liu HK, Zhu KS, He T, Younis MR, Yang C, Lei S, Wu JZ, Lin J, Qu JL, Huang P: Prussian blue-based theranostics for ameliorating acute kidney injury. J Nanobiotechnol 2021, 19:266.
15. Whitcomb DC: Acute pancreatitis - Reply. N Engl J Med 2006, 355:961-961.
16. Lankisch PG, Apte M, Banks PA: Acute pancreatitis. Lancet 2015, 386:85-96.
17. Rashidian A, Ghafari H, Chamanara M, Dehpour AR, Muhammadnejad A, Akbarian R, Mousavi SE, Rezayat SM: The protective effect of nano-curcumin in experimental model of acute pancreatitis: The involvement of TLR4/NF-kB pathway. Nanomed J 2018, 5:138-143.
18. Escobar J, Pereda J, Lopez-Rodas G, Sastre J: Redox signaling and histone acetylation in acute pancreatitis. Free Radic Biol Med 2012, 52:819-837.
19. Pasari LP, Khurana A, Anchi P, Saifi MA, Annaldas S, Godugu C: Visnagin attenuates acute pancreatitis via Nrf2/NF kappa B pathway and abrogates associated multiple organ dysfunction. Biomed Pharmacother 2019, 112:108629.
20. Yao Q, Jiang X, Zhai YY, Luo LZ, Xu HL, Xiao J, Kou LF, Zhao YZ: Protective effects and mechanisms of bilirubin nanomedicine against acute pancreatitis. J Control Release 2020, 322:312-325.
21. Perez S, Pereda J, Sabater L, Sastre J: Redox signaling in acute pancreatitis. Redox Biol 2015, 5:1-14.
22. Lavie L: Oxidative stress in obstructive sleep apnea and intermittent hypoxia - Revisited - the bad ugly and good: Implications to the heart and brain. Sleep Med Rev 2015, 20:27-45.
23. Ratliff BB, Abdulmahdi W, Pawar R, Wolin MS: Oxidant mechanisms in renal injury and disease. Antioxid Redox Signal 2016, 25:119-146.
24. Jaworek J, Szklarczyk J, Jaworek AK, Nawrot-Porabka K, Leja-Szpak A, Bonior J, Kot M: Protective effect of melatonin on acute pancreatitis. Int J Inflammation 2012, 2012:173675.
25. Chen ZJ, Vong CT, Gao CF, Chen SY, Wu X, Wang SP, Wang YT: Bilirubin nanomedicines for the treatment of reactive oxygen species (ROS)-mediated diseases. Mol Pharm 2020, 17:2260-2274.
26. Cavallini G, Frulloni L: Somatostatin and octreotide in acute pancreatitis: the never-ending story. Dig Liver Dis 2001, 33:192-201.
27. Hu JB, Li SJ, Kang XQ, Qi J, Wu JH, Wang XJ, Xu XL, Ying XY, Jiang SP, You J, Du YZ: CD44-targeted hyaluronic acid-curcumin prodrug protects renal tubular epithelial cell survival from oxidative stress damage. Carbohydr Polym 2018, 193:268-280.
28. Xiong J, Ni JB, Hu GY, Shen J, Zhao Y, Yang LJ, Shen JQ, Yin GJ, Chen CY, Yu G, et al: Shikonin ameliorates cerulein-induced acute pancreatitis in mice. J Ethnopharmacol 2013, 145:573-580.
29. Triemer S, Gilmore K, Vu GT, Seeberger PH, Seidel-Morgenstern A: Literally green chemical synthesis of artemisinin from plant extracts. Angew Chem-Int Edit 2018, 57:5525-5528.
30. Escande V, Garoux L, Grison C, Thillier Y, Debart F, Vasseur JJ, Boulanger C, Grison C: Ecological catalysis and phytoextraction: symbiosis for future. Appl Catal B-Environ 2014, 146:279-288.
31. Yim D, Lee DE, So Y, Choi C, Son W, Jang K, Yang CS, Kim JH: Sustainable nanosheet antioxidants for sepsis therapy via scavenging intracellular reactive oxygen and nitrogen species. Acs Nano 2020, 14:10324-10336.
32. Wang ZR, Zhang RF, Yan XY, Fan KL: Structure and activity of nanozymes: Inspirations for de novo design of nanozymes. Mater Today 2020, 41:81-119.
33. Zhang XJ, Lin SJ, Liu SW, Tan XL, Dai Y, Xia F: Advances in organometallic/organic nanozymes and their applications. Coord Chem Rev 2021, 429:213652.
34. Bedard K, Krause KH: The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 2007, 87:245-313.
35. Yang J, Zhang C, Zhang W, Shi R, Zhang Z: Extracellular superoxide dismutase, a potential extracellular biomarker candidate for prolactinoma. West Ind Med J 2012, 61:665-669.
36. Ma WJ, Mao JJ, Yang XT, Pan C, Chen WX, Wang M, Yu P, Mao LQ, Li YD: A single-atom Fe-N-4 catalytic site mimicking bifunctional antioxidative enzymes for oxidative stress cytoprotection. Chem Commun 2019, 55:159-162.
37. Ke SK, Lai YL, Zhou T, Li LH, Wang YG, Ren L, Ye SF: Molybdenum disulfide nanoparticles resist oxidative stress mediated impairment of autophagic flux and mitigate endothelial cell senescence and angiogenic dysfunctions. ACS Biomater Sci Eng 2018, 4:663-674.
38. Xie X, Zhao JL, Gao W, Chen J, Hu B, Cai XJ, Zheng YY: Prussian blue nanozyme-mediated nanoscavenger ameliorates acute pancreatitis via inhibiting TLRs/NF-kappa B signaling pathway. Theranostics 2021, 11:3213-3228.
39. Miao ZH, Jiang SS, Ding ML, Sun SY, Ma Y, Younis MR, He G, Wang JG, Lin J, Cao Z, et al: Ultrasmall rhodium nanozyme with RONS scavenging and photothermal activities for anti-inflammation and antitumor theranostics of colon diseases. Nano Lett 2020, 20:3079-3089.
40. Li JF, Zhou CH, Zhang J, Xu F, Zheng YT, Wang SG, Zou DW: Photo-induced tumor therapy using MnO2/IrO2-PVP nano-enzyme with TME-responsive behaviors. Colloid Surf B-Biointerfaces 2021, 205:111852.
41. Zhao JL, Cai XJ, Gao W, Zhang LL, Zou DW, Zheng YY, Li ZS, Chen HR: Prussian blue nanozyme with multienzyme activity reduces colitis in mice. ACS Appl Mater Interfaces 2018, 10:26108-26117.
42. Feng W, Han XG, Hu H, Chang MQ, Ding L, Xiang HJ, Chen Y, Li YH: 2D vanadium carbide MXenzyme to alleviate ROS-mediated inflammatory and neurodegenerative diseases. Nat Commun 2021, 12:2203.
43. Xu X, Wang SG, Wu H, Liu YF, Xu F, Zhao JL: A multimodal antimicrobial platform based on MXene for treatment of wound infection. Colloid Surf B-Biointerfaces 2021, 207:111979.
44. Chen Z, Wu H, Wang HB, Zaldivar-Silva D, Aguero L, Liu YF, Zhang ZR, Yin YC, Qiu BW, Zhao JL, et al: An injectable anti-microbial and adhesive hydrogel for the effective noncompressible visceral hemostasis and wound repair. Mater Sci Eng C-Mater Biol Appl 2021, 112422:13.
45. Zhang Y, Zhu CP, Zhang ZR, Zhao JL, Yuan YK, Wang SG: Oxidation triggered formation of polydopamine-modified carboxymethyl cellulose hydrogel for anti-recurrence of tumor. Colloid Surf B-Biointerfaces 2021, 207:112025.